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Abstract 
Role of Translation Initiation in Regulation of Epithelial Junctions and Cell Motility 
By Fahda Fawaz Alsharief, Master of Science 
This thesis is submitted in partial fulfillment of the requirements for the Master of Science 
degree at Virginia Commonwealth University. 
Virginia Commonwealth University, 2017 
Thesis Director: Dr. Andrei Ivanov, Professor, Department of Human and Molecular Genetics 
 
The integrity and barrier properties of intestinal epithelium are determined by specialized 
adhesive structures known as intercellular junctions; composed of adherens junctions (AJs), tight 
junctions (TJs) and focal adhesions that mediate cell-cell and cell matrix interactions, 
respectively. These two types of epithelial cell adhesions regulate each other during disruption 
and restitution of the epithelial barrier. Inflammatory cytokines such as interferon gamma (IFNγ) 
and tumor necrosis factor alpha (TNFα) are elevated during intestinal inflammation. The most 
notable effects of IFNγ and TNFα on intestinal epithelial homeostasis involve disruption of 
apical junctions and attenuation of cell migration. Although molecular mechanisms underlying 
these effects remain poorly understood, expressional downregulation of different adhesion 
proteins may play a major role in the cytokine-dependent disruption of the intestinal epithelial 
barriers. This thesis is based on the hypothesis that inhibition of the protein translation initiation 
machinery promotes the disruption of the intestinal epithelial barrier and attenuates epithelial 
restitution during mucosal inflammation. This study was focused on two eukaryotic translation 
initiation factors, eIF4G1 and eIF4G2, which play essential roles in the regulation of cap-
dependent protein translation.  Expression of both translation initiation factors was dramatically 
downregulated in model intestinal epithelial cell monolayers treated with IFNγ and TNFα in 
parallel to cytokine-induced disruption of the epithelial barrier. siRNA or shRNA-mediated 
downregulation of either eIF4G1, or eIF4G2 increased permeability of well-differentiated SK-
CO15 intestinal epithelial cell monolayers and decreased expression of different adherens 
junction and tight junction proteins.  Furthermore depletion of these translation initiating factors 
inhibits different modes of migration (wound healing and transfilter migration) of stem-cell like 
 xii 
and well-differentiated intestinal epithelial cells.  These findings suggest that eukaryotic 
translation initiation factors of the eIF4G family play unique roles in regulating integrity and 
restitution of the intestinal epithelial barrier. Downregulation of these translation initiating 
factors may mediate disruption of the intestinal epithelial barriers during mucosal inflammation.  
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1. INTRODUCTION 
 
 
1.1 Role of Intracellular Junctions  
 
Intercellular junction plays a crucial role by forming the barriers and keeping the tissue integrity 
in a multicellular organism. Epithelial barriers protect the body interior of mammalian species 
from external environments, and working as defending line between invading pathogens and the 
immune system of the host. This is true in the gastrointestinal tract, especially in the intestines, 
where the epithelial barrier plays a vital role in transporting nutrients and water, and preventing 
contamination which results from microbial intestinal tissues [5, 6]. As mentioned before the 
epithelial barrier is formed by intercellular junctions which are created by plasma membrane. 
Intercellular junctions are composed of scaffolding and adhesive proteins that are attached to 
different types of cytoskeletal structures such as microtubules, actin filaments, and intermediate 
filaments. These intercellular adhesive structures include various types of junctions: Tight 
Junctions (TJ), Adherens Junctions (AJ), Gap Junctions (GJ), and Desmosomes [7]. AJs, TJs, 
and desmosome are the more abundant junctions present in the apical side of the epithelia; these 
together form what is called apical junction complex (AJC) [7, 8]. The AJC  maintains the 
characteristic of the epithelia by controlling permeability, polarity, adhesion and cell growth [9]. 
Both TJ and AJ are composed of transmembrane proteins and peripheral membrane proteins. 
Transmembrane proteins involve claudins, occludin, JAM-A, cadherin, and nectin, which are 
involved in homotypical trans-interaction. Whereas, peripheral membrane proteins ‘cytosolic 
plaque’ consists of the catenin, afadin and “zonula occludens” (ZO) family of proteins which 
stabilize the adhesive component of the AJC [7, 10]. Epithelial barrier is disrupted during the 
acute inflammatory phase thus amplifying inflammation, while the barrier is restored during the 
remission step, which helps to reduce inflammatory events [7]. The invading pathogenic 
microorganisms release a variety of agents which disrupt the epithelial barriers on the apical side 
of epithelial layers, such as, bacterial lipopolysaccharide, poreforming toxins, and cytoskeleton 
modifying proteins. However, on basal side, the barrier disruption will be increased by moving 
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activated immune cells to sites of pathogen invasion. The epithelial permeability will be 
increased by releasing reactive oxygen species (ROS) and proteases, or by secreting 
proinflammatory cytokines—such as, tumor necrosis factor (TNF), interleukin (IL), and 
interferon (IFN)—through mucosal immune cells. Increasing the permeability of the epithelial 
barrier is well-documented in different immune diseases and gastrointestinal diseases, such as 
inflammatory bowel disease (IBD), irritable bowel syndrome, gastric ulcer, celiac disease, food 
allergies, asthma, sepsis, cancer (esophagus, and colorectal) and type 1 diabetes [11, 12]. 
Accordingly, understanding the mechanisms that control the disruption of epithelial barrier is the 
main key to investigate molecular targets of mucosal inflammation.  
 
 
 
 
 
Fig 1.1: - Important Components of Intercellular Junctions in Mammalian Cells. 
Intercellular adhesions are mediated by specialized plasma membrane structures termed junctions; TJ, AJ, GJ 
and, Desmosomes. Adapted from Tsukita S. Nat Rev Mol Cell Biol, 2001 
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1.2 Molecular Compositions of Epithelial Junctions  
1.2.1 Tight Junction 
TJs are present in all types of epithelial cells, involving epithelial and endothelial cells. They are 
placed next to AJs in the most apical part of junctional complexes of epithelial cells [13]. Under 
the electron microscopy, TJs appear as zones of adjacent intercellular contacts sealing the 
paracellular space [11]. The TJs play the key role in regulating the movement of ions and solutes 
intercellularly and intracellularly [10].  They also establish the apico-basal cell polarity, and 
create the paracellular barrier [11]. Permeability and permselectivity are the main functions of 
TJs which can be determined in the lab by specific experiments. Permeability is a quantitative 
characteristic of TJs which can be measured by transepithelial electrical resistance (TEER), 
while the permselectivity is a qualitative feature of TJs which determines the transports of either 
cations or anions. For example, gastrointestinal epithelia classified depending on their 
permeability on three main categories: leaky, moderately, and tight. Leaky epithelium, which 
presents in the small intestine, has TEER under 200 W cm2. Moderately leaky epithelium, which 
found in colon, has TEER between 300-1000 W cm2. Whereas, tight epithelium barrier has 
TEER above 1000 W cm and presents esophagus. To study the regulation of TJs in vitro, human 
colonic carcinoma derived epithelial cell lines can be used. For instance, Caco 2 cells can be 
used to study the moderately leaky, while T84 and SK CO15 have been used to study tight 
barriers [11]. 
As many intercellular junctions, the molecular composition of TJs have been identified as 
transmembrane proteins (integral membrane proteins), and peripheral membrane proteins 
(cytoplasmic scaffolding plaque). The transmembrane proteins, which mediate cell‑cell 
adhesions and create the paracellular barrier, consist of major types of integral proteins: claudin 
family; tight junction‑associated MARVEL proteins (TAMP) family which includes occludin, 
tricellulin, and marvelD3; and immunoglobulin‑like proteins such as junctional adhesion 
molecule  (JAM)‑A  and  coxsackievirus  and  adenovirus receptor (CAR)[11]. 
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Occludin and claudin are considered as a core of TJ and regulate the permeability and selectivity 
of paracellular pathway of ions between adhering cells [10, 11, 13]. The peripheral membrane 
proteins, which form cytosolic scaffolding plaque and regulate TJ stability and remodeling, have 
five molecular component proteins:  Zonula occluden family (ZO-1, ZO-2, ZO-3), cinguilin, and 
afadin. Zonula occluden family is considered as prototypical components of the cytosolic plaque 
of TJ and has membrane-associated guanylate kinase (MAGUK) which binds to C-terminal of 
JAM-A, claudin, coxsackievirus and adenovirus receptor (CAR), and occludin by PDZ and SH3 
domains[10, 11, 13]. Zonula occluden family and claudin are essential components to form TJ 
strands in epithelial cells, while other transmembrane proteins such as occludin help to regulate 
TJ strand formation with claudins [11, 13].   
 
 
 
 
 
Fig 1.2: - Molecular Composition of Tight Junctions. TJ transmembrane proteins (claudins, occludin, 
JAM-A), cytosolic plaque proteins (ZO proteins, cingulin, MAGI), they associate with underlying actin 
filaments. Adapted from Journal of Investigative Dermatology Volume 127, Issue 11, [2] 
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1.2.2 Adherens Junction 
 
Adherens junctions establish cell-cell contacts, regulate the maturation, and maintain the 
connecting network[10]. Their proteins perform several functions: they control the formation and 
assembly of tight junctions, which seal the paracellular space [14]; they regulate the initiation of 
intracellular signaling, membrane receptor, transcription, oncoproteins, and the actin 
cytoskeleton; and they stabilize the cell-cell adhesion [10, 15]. The complex of adherens 
junctions are composed of the transmembrane proteins cadherin and nectin, which interact with 
adjacent cells and with intracellular cytosolic plaque, such as catenin and afadin. Cadherin and 
nectin are the core of transmembrane protein of epithelial adherens junction [7, 10, 16]. 
Together, these proteins regulate the function of adherens junctions [10, 17]. Cadherin is 
considered as the large superfamily of calcium-dependent adhesion cell molecules, which 
contains multiple copies of extracellular cadherin domain (EC) in the extracellular region. This 
EC initiates trans-cadherin interactions between adjacent cells and helps to form the adherens 
junctions [10]. Cadherins regulate the cell-cell interaction and cell movement and maintain the 
tissue morphogenesis to keep the cell architecture in the adult. Also, they play a significant role 
in the development by controlling the cell segregation and formation of the interfaces in distinct 
tissue [16, 18, 19]. Increasing invasive phenotype of tumor cells is often correlated to loss or 
downregulation of cadherins [18]. E-cadherin is the main transmembrane glycoproteins and one 
of Ca2+ dependent adhesion proteins [7, 10].  It is necessary for localization and binding to 
catenins which is the part of cytoplasmic proteins that connect the cadherin proteins to actin 
cytoskeletons[10]. The cytosolic plaque of the AJ is composed of two armadillo family proteins: 
catenin and afadin [7]. The Catenin family involves alpha-catenin, beta-catenin, and p120- 
catenin. These cytosolic plaque proteins regulate local actin assembly by interacting with 
intercellular domains of E-cadherin through beta-catenin, which binds directly to alpha catenin 
and p120 catenin [14]. The decreasing in the expression of E-cadherin is responsible for 
incorrect localization of catenins and other TJ proteins [7, 10].  
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Fig 1-3: - Molecular Composition of Adherens Junctions. AJ formed by transmembrane 
proteins (cadherins, nectins), cytosolic plaque proteins (catenins, afadin), they associate with 
underlying actin filaments. Adapted from Journal of Investigative Dermatology Volume 127, Issue 
11, [2] 
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1.3 Basic Mechanism of Cell Motility 
 
Cell motility, a complex and highly integrated process, is essential for multiple biological 
processes, such as the development of organisms (morphogenesis), neurogenesis, wound healing, 
and immune response. Also, it drives the disease progression in cancer metastasis, mental 
retardation, arthritis, and atherosclerosis [20, 21]. The mode of the cell migration, which 
determines if the cell migrates individually (amoeboid or mesenchymal) or collectively 
(migration of cohesive multicellular units) depends on cytoskeleton organization, type of cell-
matrix interaction and force generation, and modification of tissue structure imposed by 
migrating cells[22]. These two modes of cell motility are known as Collective Cell Migration 
and Individual cell migration respectively. The first mode of the cell migration is when the cells 
move collectively in a sheet like structure, in the presence of cell-cell junctions; this type of 
movement is observed during wound healing in epithelial cells. In contrast, another type of cell 
motility is Individual Migration, which happens by separation of cells from each other and move 
as a single cell by suppression of intercellular junctions and downregulation of cadherins. In the 
case of individual cell migration, there are two main types of the cell morphology, which use the 
different mechanism of migration. The first one is elongated, fibroblast-like cells, which undergo 
mesenchymal migration. The mesenchymal migration of the elongated morphology cells 
depends on integrin-mediated adhesion with substrate and degradation of extra cellular matrix 
(ECM) by the matrix-degrading protease which presents in the leading edge of migrating cell. 
The second type of the individual cell morphology is rounded cells which undergo amoeboid 
migration. Because the cell- substrate adhesion is weak, cells appear as a rounded morphology.  
Rounded cells move by amoeboid migration in an integrin-independent adhesion, and they do 
not require the ECM degradation. By changing the shape and squeezing themselves through the 
gap in ECM, the rounded cells can migrate through it. Thus, the transition from collective 
migration to individual migration is called the Epithelial-Mesenchymal transition. The basic cell 
motility depends on the reorganization of actin cytoskeleton and consists of four main processes: 
protrusion, adhesion, translocation, and retraction. First, cells motility is triggered by external or 
internal signaling which interacts with the extracellular receptors and activates the downstream 
signaling. The stimulated asymmetric cells and de novo actin filaments polarization occur at the 
leading edge. Then, the formation of membrane protrusion such as filopodia and lamellipodia 
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occurs by polarized actin filaments which push against the cell membrane. Secondly, this 
protruded membrane attaches to ECM and initiates the novel integrin dependent cell substrate 
adhesion formation at the leading edge. The adhesion complexes which recently formed are 
stabilized and mature into focal adhesion. Thirdly, translocation of the nucleus and cell body 
activated by acto-myosin contractile forces distort the cells into an elongated shape. Finally, 
disassembly of focal adhesion and release of cell-substrate rear adhesion allows the tail retraction 
[1, 23-27].     
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Fig 1-4: - Basic Cycle of Cell Motility. [1] Cancer Science Volume 96, Issue 7, pages 379-386, 29 
JUL 2005 DOI:10.1111/j.1349-7006.2005.00062.x 
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1.4   Mechanism of Eukaryotic Translation  
Translation of mRNA into protein is one of the multiple levels of regulated gene expression. By 
allowing more rapid changes in the cellular concentration of encoded protein, the translation 
process maintains the homeostasis in cell physiology and fate. The process of translation is 
composed of four main steps: initiation, elongation, termination, and ribosomal recycling. 
Multiple different protein factors involved in the translation mechanism interact with mRNA, 
transfer RNA(tRNA), and 40S ribosome, where the codon is located, and 60S ribosome. These 
interactions promote each stage of the translation process and ensure a mRNA is accurately 
translated into protein. Generally, during the initiation stage, the elongation-component 80S 
ribosome is formed by recruiting the mRNA to the 40S ribosome and the 60S ribosome. In the 
elongation step, the information in each nucleotide triplet (or codon) will be translated into 
amino acids by migrating 80S ribosome along the mRNA. These translated amino acids will be 
incorporated into a growing polypeptide chain.  During the termination, the newly formed 
protein is released by recognizing the stop codon. Lastly, in ribosome recycling, the mRNA and 
80S ribosome is released. the 80S ribosome will be separated into its original components: the 
40S and 60S subunits, which can then begin the translation cycle again[28, 29].  
1.4.1  Eukaryotic Translation Initiation Step 
Translation initiation is considered as the rate-limiting step of protein synthesis, and as such, it is 
the most highly regulated phase of translation [28-30]. The variance of the initiation rates can be 
due to differences in regulatory features of mRNA, such as highly structured 5' un-translated 
region (UTR). Another variance could be the regulation of initiation factors by signaling 
cascades, such as mitogen-activated protein kinase (MAPK) pathway and mechanistic target of 
rapamycin (mTOR). Together, these variances have an effect on availability and activity of 
factors which alter the rate of translation [28]. Compared to prokaryotes, the initiation of protein 
synthesis in eukaryotes consists of the recruitment of a ribosome initiator tRNA complex to 
mRNA initiation codon. Whereas, in prokaryotes, this process occurs by direct interaction of 
ribosomal RNA with the mRNA. Eukaryotes have a highly regulated mechanism that relies on 
the interaction between the proteins and between protein and the mRNA. 
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 As a result, the eukaryotic translation initiation has at least eleven different initiation factors 
which are required for translation initiation to occur accurately. Together these factors ensure 
that the methionyl-initiator tRNA (Met-tRNAiMet), which is placed in the ribosomal P site, is 
base paired with the initiator AUG codon of an mRNA. Conceptually, the eukaryotic initiation 
process, which leads to formation of 80S ribosome, consists of multiple linked steps which are 
mediated by eukaryotic translation initiation factors (eIF). This process can be divided into five 
main stages: First, the eIF4F cap-binding complex binds to mRNA; second, a formation of the 
43S preinitiation complex (PIC); third, recruitment of mRNA to the ribosome; fourth, 
localization of in initiation codon; finally, 80S ribosome will be formed by joining of a 60S 
ribosome and 40S ribosome. First, to recruit the target mRNA to the 40S subunit, the mRNA 
should be prepared by recognizing and binding to eIF4F complex and PABP. The eIF4F 
complex is composed of: three main subunits (eIF4E, eIF4A, eIF4G); and eIF4B as an auxiliary 
factor. Together these subunits promote unwinding of secondary structure in 5' UTR by eIF4A. 
The 40S subunit is prepared to recruit to mRNA by several eIF factors which bind individually, 
or as a multifactor complex. These binding factors include: eIF1, eIF1A, eIF2, eIF3, and eIF5. 
The eIF2 binds as a ternary complex which includes eIF2-TC with GTP and the initiator tRNA. 
Through direct interaction between eIF4G and eIF3, mRNA is directed to the ribosome. 
Following the step of recruitment, 40S subunit begins scanning for initiation codon by traveling 
along mRNA in 5' to 3' direction, and sampling codons on the mRNA with initiator tRNA 
anticodon. After recognition of initiation codon by base-pairing, GTP in eIF2-TC is hydrolyzed 
by eIF5.The eIF2-GDP complex and other initiation factors from 40S are released. By eIF2B, 
eIF2 recharges with GTP, and new initiator tRNA is recruited to reform the eIF2-TC. Now, the 
initiation factors are free to begin the new round of translation on different mRNA. Until eIF5B-
GTP recruits and binds 60S subunits, eIF1A interacts with the 40S subunit. In the end, both of 
eIF1A and eIF5B-GTP are released following the GTP hydrolysis. Lastly, the newly 80S 
ribosome is formed and then enters the elongation cycle, which is followed by the termination 
and the recycling steps which results in the release of free 40S and 60S subunits.  These released 
subunits are prepared for future rounds of translation [28, 29, 31, 32].   
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Fig 1.5: - Translation Initiation Mechanism. To form the 43S pre-initiation complex (purple), the 40S 
ribosomal subunit (green) interacts with eukaryotic initiation factor 2 (eIF2), GTP and initiator methionyl tRNA. The 
eIF4F complex (red), which composed of eIF4E, eIF4G, eIF4A, and eIF4B as an auxiliary factor. Together these 
factors bind with 43S, is then recruited to the 5' cap. Poly(A) binding protein (PAB; yellow) bound to 3’ end of mRNA 
poly(A) tail in order to facilitate translation initiation by communicating with the 5' end of the mRNA through its 
interaction with eIF4G, as a result, the 5' and 3' ends of the mRNA are joined. Then, the 43S complex scans the 
mRNA until the AUG codon is recognized. This stimulates eIF5 to hydrolyze GTP, as a result of GTP hydrolysis, the 
eIFs dissociate and the 60S subunit joins. In the end, a fully functional ribosome is ready to begin peptide synthesis. 
Adapted from Nat Rev Genet. 2003 Aug;4(8):626-37.[4] 
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1.4.2  Importance of eIF4G Family in Translation Initiation Mechanism 
There are two fundamental features in which the mRNA is selected for translation: 7'-methyl-
guanosine cap binds to 5' end of mRNA; and poly(A) tail is added to 3' end of mRNA. These two 
characteristics are protecting mRNA from the degradation and are promoting the translation 
initiation. The eukaryotic translation initiation factor 4F(eIF4F) is a heterotrimeric factor, which 
is composed of three subunits eIF4E, eIF4G, and eIF4A. These subunits work as cap binding, 
molecular scaffold, and DEAD box helicase (ATP-dependent RNA helicase), respectively. Also, 
it interacts with 7' methyl-guanosine, and 3' ploy (A) tail directly or indirectly. The fundamental 
role of eIF4F is to place in 5' end of mRNA through eIF4E (cap recognition) and to ensure the 5' 
end of mRNA will bind to the 40S ribosome.  The eIF4G is considered as the largest and core 
component of eIF4F and is sufficient for efficient ribosomal attachment to capped mRNA. The 
eIF4G contains the binding domains for mRNA, eIF4A, eIF4E, eIF3, poly(A) binding 
protein(PABP), and MAPK-interacting kinase(MNKs). By these binding domains, eIF4G works 
as molecular scaffolding which regulates and recruits the activation of other eukaryotic 
translation initiation factors. It also increases the affinity of the interaction between 5' mRNA cap 
structure to eIF4E, and 3' mRNA poly(A) tail to PAPB. The eIF4G promotes the ability of eIF4A 
to stimulate the translation by recruiting eIF4A and activating its ATP-dependent RNA helicase 
activity. Beside the stabilizing the affinity, eIF4G has two additional essential functions in 
mRNA recruitment to the ribosome. This recruitment occurs through interaction between eIF4G 
and eIF3. Additionally, eIF4G works as the bridge in 43S PIC and eIF4F-mRNA complex by 
interacting with eIF3. The eIF4G interacts with eIF4A (DEAD box helicase) and holds its active 
confirmation; this interaction is required to recruit this helicase to mRNA. DEAD box helicase 
facilitates the ribosome recruitment and scanning through unwind secondary structure of mRNA 
located in 5' UTR in an ATP-dependent manner. It is believed that the eIF4G directly recruits the 
43S PIC through the physical interactions with eIF3 and eIF5 in the PIC [28, 32-36].  
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Fig 1.6: - Main Role of eIF4G family protein in Translation initiation Stage. eIF4G subunits are 
considered the largest component of the eIF4F family; these subunits contain the binding domain for mRNA, PABP, 
eIF4A, eIF4E, and eIF. They also stabilize the interaction of eIF4E with cap structure;and PABP with the poly A tail. 
Additionally, they directly interact with eIF3, component of 43S Ribosome, and work as bridge between eIF4F – 
mRNA complex, and 40S Ribosome. Adapted from Biol Res. 2005;38(2-3):121-46.[3] 
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1.5 Why we Study the Role of Translation Initiation in Regulation of the 
Epithelial Junctions and Cell Motility? 
In this study, the overall goals were to investigate the role of eukaryotic translation initiation 
factor (eIF4G) in regulating structure and functions of apical junctions, and motility of intestinal 
epithelium and ECM adhesion; and to analyze the roles of eIF4G downregulation in cytokine 
induced barrier disruption and inhibited epithelial restitution. There are several reasons for 
focusing on translation factor eIF4G on regulating of epithelial junctions and cell motility. First, 
epithelial barrier is disrupted during the acute inflammatory phase thus exaggerating 
inflammation. Disruption of AJ, TJ, and FA plays a key role in the breakdown of the intestinal 
epithelial barrier during the mucosal inflammation [37-39]. For instance, proinflammatory 
cytokines relevant to IBD are known to trigger AJ and TJ disassembly and attenuate wound 
healing in model intestinal epithelial cell monolayer [40]. Decreased expression of adhesion 
proteins has been reported in IBD mucosa and cytokine-treated epithelial cells [41, 42], which 
plays a significant role in mediating breakdown of the intestinal epithelial barrier[43]. Second, 
mechanisms of cytokines-dependent downregulation of adhesion proteins remain poorly 
understood, although evidence suggests that they may involve posttranscriptional events. Protein 
translation is an attractive mechanism since it is known to be down-regulated by inflammatory 
stimuli in colonic and pancreatic epithelium[6, 44]. Third, little is known regarding the roles of 
eIF4G1 and eIF4G2 in regulating the expression of the epithelial adhesion proteins. The eIF4G1 
was previously implicated in the control of p120 catenin expression in inflammatory breast 
cancer [45]. Furthermore, eIF4G1 was found to be enriched at the leading edge of migrating 
fibroblasts [46, 47] and to regulate tumor cell invasion[45, 48]. However, nothing is known 
about the roles of eIF4G translational initiator in regulating the integrity and restitution of the 
intestinal epithelial barrier under normal conditions or during mucosal inflammation. Based on 
this, we hypothesized that the process of translation initiation plays essential roles in regulation 
of the intestinal epithelial apical junctions and cell motility in intestinal models. 
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1.6 Specific Aims  
 
Aim 1: To investigate the roles of eIF4G-dependent translation of AJ and TJ proteins in the 
maintenance and disruption of model intestinal epithelial barrier. 
 
Aim2: To analyze the involvement of translation initiation factors in intestinal epithelial cell 
migration and ECM adhesion. 
 
Hypothesis: The process of translation initiation plays essential roles in regulation of the 
intestinal epithelial apical junctions and cell motility in intestinal models. 
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2.  MATERIALS AND METHODS 
2.1 Cell Culture 
Different intestinal epithelial cells that were used were maintained in standard T-flasks.  HIEC, 
SC-CO15, T84, and HT29 were plated either onto 6 or 24 well plates depending on the 
experiment. Cells were allowed to grow in nutrient media until a confluency of 60-80%. The 
table provided describes the different components of a nutrient medium which were used for cell 
growth. 
Cell Type Basic Medium Source Serum Used MEM-NEAA HEPES Pen-step Cat # 
 
 
SK-CO15 
 
 
DMEM 
 
 
ATCC 
 
 
FBS 10% 
 
 
5 ml 
 
 
7.5 ml 
 
 
 
5ml 
 
 
30-2002 
 
 
HT 29 
 
 
DMEM 
 
 
ATCC 
 
 
FBS 10% 
 
 
5 ml 
 
 
7.5 ml 
 
 
 
5ml 
 
 
30-2002 
 
 
T84 
 
 
 
DMEM/F12 
 
 
Corning 
 
 
FBS 20% 
 
 
---- 
 
 
---- 
 
 
 
5ml 
 
 
10092CV 
 
 
HIEC 
 
 
OptiMEM 1 
 
 
Invitrogen 
 
 
FBS 5% 
 
 
5ng/ml 
EGF 
 
 
0.05 M 
 
 
 
 
---- 
 
 
22600-134 
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2.2 Total Cell Lysates 
In order to make lysate, cells were washed three times with HANK's+ on ice. After adding RIPA 
buffer, cells were scraped from 6-well dishes by using cell scraper. The RIPA buffer, which is 
formed by (20mM Tris, 1% Sodium Deoxycholate, 1% Triton, 50mM  NaCl, 20mM EGTA, 
2mM EDTA), should contain protease inhibitors (1:100) and phosphatase inhibitors cocktail 
(1:200)—both were obtained from Sigma-Aldrich to protect protein's integrity and protein 
phosphorylation. Cell were homogenized using Dounce Homogenizers. Then homogenized 
samples then were centrifuged for 20 mins at 14,000G, 4°C, and supernatant was diluted in the 
equal amount of 2x SDS sample buffer after adding 0.1M Dithiothreitol (DTT). Lastly, samples 
were boiled for 6 mins in 100°C, and then stored in -80°C refrigerator. By using BCA protein 
assay kit, (ThermoFisherScientific) the protein concentration of total lysate is determined.  
2.3 Western Blotting/Immunoblotting  
Sodium Dodecyl Sulfate - Polyacrylamide Gel Electrophoresis (SDS-PAGE) was used to 
separate individual proteins. An equal amount of total protein was loaded into each lane (10-
20ug). After the electrophoretic separation, proteins were transferred by electroblotting technique 
onto polyvinylidene difluoride (PVDF) or Nitrocellulose membranes according to the molecular 
weight of the proteins. The membrane was then blocked with 5% Non-fat dry milk, diluted into 
TBS-T (Tris-Buffered Saline-Tween-20) for an hour. After that, the primary monoclonal or 
polyclonal antibodies were added and incubated overnight in a cold room. On the second day, 
the membranes treated with primary antibodies were washed three times with TBS-T for 5 
minutes each to remove all excess primary antibodies. Then HRP conjugated secondary 
antibodies were added to the membrane for an hour at 1:5000 concentration. Then, membranes 
were washed with TBS-T three times, followed by three more times washing with TBS for five 
minutes each. Finally, membranes were developed by using ECL reagent from GE-Healthcare. 
The images were taken on standard x-ray film by using SRX-101A image processor from Konica 
Minolta. 
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2.4 siRNA–Mediated Protein Knockdown  
Cells cultured on 6-well plates were transfected with gene specific siRNA in order to obtain 
transient protein knockdown. Eif4G1 and Eif4G2 gene silencing was obtained using specific On-
Target+ siRNA from GE-Lifesciences. The siRNA is specifically designed to reduce off target 
effects. As per the mechanism stated by the manufacturer, the sense strand is modified to prevent 
interaction with RISC-complex and thus favors anti-sense strand uptake while the anti-sense 
strand is modified to destabilize off-target effects and enhance target specificity (Manufacturer’s 
manual, GE-Lifesciences). All knockdowns were performed as per manufacturers protocol. 
Control siRNA duplex#2 obtained from GE-Lifesciences was used as control in all experiments. 
 
2.5 Generation of Stable Cell Lines with Small Harpin (sh)RNA-Mediated 
eIF4G1 and eIF4G2 Knockout 
 
HIEC, and SK-CO15 cell lines with stable shRNA-mediated knockdown of either Eif4G1 or 
Eif4G2 were generated using the Sigma-Aldrich MISSION shRNA Lentiviral Transduction 
system according to the manufacturer's instructions (Sigma-Aldrich, Saint Louis, MO). All cell 
lines were transduced with either Eif4G1 or Eif4G2 shRNA-containing lentiviral particles, and 
stable cell lines were selected using puromycin (3 μg/mL for HIEC and 5 μg/mL for other three 
lines, respectively). A non-silencing shRNA lentiviral particle (RHS4346), lacking 
complementarity to any human gene, was used as a control. 
 
2.6 Antibodies and other reagents 
The following commercially-available primary polyclonal (pAb) and monoclonal antibodies 
(mAb), which have already been tested in our laboratory, will be used in the proposed study: anti 
eIF4G1, eIF4E (Cell Signaling Technology Danvers, MA), Eif4G2 (Bethyl Laboratories, 
Montgomery, Tx), anti-occludin, ZO-1, JAM-A, pAbs and anti-E- cadherin, occludin, ZO-1 
mAbs (Life Technologies, San Francisco, CA); anti-β-catenin (BD Biosciences, San Diego CA.) 
Anti-puromycin mAb (Kerafast Boston, MA) Alexa-488-conjugated G-actin, rhodamine- 
phalloidin, as well as Alexa-488 or Alexa-568 dye-conjugated donkey anti-rabbit and goat anti- 
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mouse secondary antibodies will be obtained from Invitrogen (Eugene, OR); horseradish 
peroxidase-conjugated goat anti-rabbit and anti-mouse secondary antibodies will be obtained 
from Jackson Immunoresearch Laboratories (West Grove, PA). All other reagents will be 
purchased from Sigma-Aldrich. 
2.7 Immunofluorescence Labelling and Confocal Microscopy 
Intestinal epithelial cells either transfected with siRNA against eIF4G1, and eIF4G2 or stable cell 
lines with shRNA mediated knockdown, were grown in a collagen-coated coverslip in 24 well 
dishes. Confluent cells on 4th-day post-transfection were fixed in 100% Methanol for 20 minutes 
at -20°C. After fixation, the cells were blocked by using Bovine Serum Albumin (BSA) in the 
dark for one hour. Combination primary antibodies, which were prepared by diluting them in 
BSA (1:300), were added to cells for an hour. Then, the cells were washed three times with BSA 
for five minutes each. Next appropriate secondary Antibodies diluted in BSA at 1:1000 were 
added. Next cells were washed three times with BSA for five minutes each. Lastly, coverslips 
were placed on the glass slide using Prolong Gold Antifade reagent (Applied Biosystems). 
Stained cells were examined by using a Zeiss LSM 700 Laser scanning microscope. The images 
were analyzed by using Zen Lite software (Carl Zeiss Microscopy).  
2.8 Puromycin Incorporation Assay 
Intestinal epithelial cells either transfected with siRNA against eIF4G1, and eIF4G2 or stable cell 
lines with shRNA mediated knockdown, were grown in a collagen-coated coverslip in 24 well 
plates. On the day of the experiment a using 200 ul pipette a scratch wound was created. Cell 
were allowed to move and 3h post-wounding samples were treated with DMEM containing 5 μM 
puromycin for 30 min prior to cell fixation. Cells were washed two times with HANK’S and 
proceeded to staining with anti-pyrumycin antibody to detect the newly translated proteins.  
2.9 Transepithelial Electrical Resistance (TEER)  
Transepithelial electrical resistance (TEER) of cultured epithelial cell monolayers was measured 
using an EVOMX voltohmmeter (World Precision Instruments, Sarasota, FL). The resistance of 
cell-free collagen-coated filters was subtracted from each experimental point. 
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2.10 Wound Healing Assay/ Scratch Assay 
Intestinal epithelial cells either transfected with siRNA against eIF4G1, and eIF4G2 or stable cell 
lines with shRNA mediated knockdown, were grown on 6-well plates. On the 4th day post-
transfection, a horizontal thin scratch wound was performed in the confluent area of the cells 
monolayer by using a 200μl pipette tip. After making the scratch, the previous medium was 
removed and replaced by new one. Images of the scratch were capture in 0h, 24h, and 48h 
depending on the cell types. After that, the cell-free area was measured by using Image J 
software. 
2.11 Spreading Assay 
Intestinal epithelial cells either transfected with siRNA against eIF4G1, and eIF4G2 or stable cell 
lines with shRNA mediated knockdown, were grown on 6-well plates. On the 4th day post-
transfection, cells were detached from plates by using TrypLE Express and counted with the 
hemocytometer after they were re-suspended in standard medium. First, 24 well plates were 
coated with 200μl of type-1 collagen and incubated overnight in order to dry. Then, 107 cells 
were seeded onto the plates. The cells were incubated for one hour to allow the cells to attach 
and spread over collagen type 1 at 37°C. Then, the cells were fixed with 70% ethanol for 10 
minutes and stained by using DIFF stain kit. Lastly, the images of spread cells were taken by 
light microscope under 20x power and the area of spreading was measured by Image J software. 
2.12 ECM Adhesion Assay 
Intestinal epithelial cells either transfected with siRNA against eIF4G1, and eIF4G2 or stable cell 
lines with shRNA mediated knockdown, were grown on 6-well plates. On the 4th day post-
transfection, cells were detached from plates by using TrypLE Express and counted with the 
hemocytometer after they were re-suspended in standard medium. Then, 107 cells were seeded 
onto 24 well plates which coated with type-1 collagen overnight. The cells then incubated for 
one hour at 37 °C to allow the attachment of the cells to ECM. After incubation, the Non-
attached cells were removed by extensive washing up and down with 1ml of cell culture 
medium. Then the cells were fixed with -20°C methanol for 10 minutes.  
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Then the cells were stained by using a DIFF stain kit. The staining-adherent cells were examined 
by using light microscope under power 10x, and the number of adherent cells was manually 
counted. 
2.13 Transfilter Migration Assay 
In order to perform Transfilter migration assay24 well plates each with Transwells® with 8.0μm 
pore size inserted in was used (Corning Incorporated, Costar®). The 50ul of the collagen type 1 
was coated on the membranes and incubated overnight. Then, on the 4th day post-transfection, 
cells were detached from 6 well plates by using TrypLE Express and counted with the 
hemocytometer after they were re-suspended in 0.1 % FBS medium and added to the upper 
chamber of the . In contrast, the complete standard medium 10% FBS was added to the lower 
chamber of the Transwells which were previously prepared on the night before. The cells were 
incubated for 24h at 37°C to allow them to migrate overnight. After 24h, cells were fixed by 
using Methyl Alcohol from DIFF Stain Kit for 5 minutes. By using cotton swabs, the non-
migrating cells were removed from the top of the filtered membrane. The cells in the bottom of 
the filtered membrane were stained with DAPI (nuclear stain), and the filters were mounted on 
microscope slides. By using the fluorescence microscope, the migrating cells were examined and 
counted manually.  
2.14 Cytokines and Pharmacological Inhibitors Treatment 
For cytokine treatment, IFNγ (50 ng/ml) and TNFα (10 ng/ml) were added to both the cells in 6-
well plates in order to harvest the cell lysate for immunoblotting, and in apical and the 
basolateral Transwell chambers of 24 well plates for 24h and 48 h to perform immunofluorescent 
staining. In the case of Pharmacological inhibitors treatment, which involves Ribavirin (20 μM) 
and 4EGI-1 (25μM), were added to 60-80% confluent cell in 6-well dishes and make wound 
after 2h post-treatment incubation. The images were obtained in 0h, 12h, and 24h post-wounded 
depending on the types of the cells. The appropriate dimethyl sulfoxide (DMSO) was added to 
control samples. 
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2.15 Quantitative Real-Time RT-PCR 
Total RNA was isolated using an RNeasy mini kit (QIAGEN, Valencia CA), followed by DNase 
treatment to remove genomic DNA. Total RNA (1 µg) was reverse transcribed using an iScript 
cDNA synthesis kit (Bio-Rad Laboratories). Quantitative real-time RT-PCR was performed 
using iTaq Universal SYBR Green Supermix (Bio-Rad Laboratories) and a 7900HT Fast Real-
time PCR System (Applied Biosystems; Foster City, CA).  
 
The following primers were used for Claudin 4: forward: 5’-CCCCAGTGACAAAAACCC-3’; 
and reverse: 5’-ACGGACTTAAACGTTCGCA-3’.  
β-Catenin: forward: 5’- ACAAACTGTTTTGAAAATCCA-3’; and reverse: 5’- 
CGAGTCATTGCATACTGTCC-3’. 
E-cadherin forward: 5’-TTACTGCCCCCAGAGGAT-3’; and reverse: 5’-
TGGAACGTCGTTACAGTG-3’.  
Expression levels were normalized to the house-keeping gene GAPDH (forward: 5’-
CATGTTTGTGATGGGTGTGAACCA-3’); reverse: (5’-
AGTGATGGCATGGACTGTGGTCAT-3’). 
 
 The threshold cycle number (Ct) for specific genes of interest and the housekeeping gene was 
determined based on the amplification curve representing a plot of the fluorescent signal 
intensity versus the cycle number. The relative expression of each gene was calculated with a 
comparative Ct method that is based on the inverse proportionality between Ct and the initial 
template concentration (2-ΔΔCt), as previously described [49]. This method is based on the two-
step calculation of ΔCt = Ct target gene – Ct GAPDH and ΔΔCt = ΔCte-ΔCtc where indexe 
refers to the sample from any control  or eIF4G1 and eIF4G2 siRNA or corresponding miRNA 
treated cells, and index c refers to a sample from a control siRNA or control miRNA-treated cells 
assigned as an internal control. 
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3. RESULTS- PART I 
 
3.1 Proinflammatory Cytokines Induce Disassembly of Intestinal Epithelial 
Tight and Adherens Junctions. 
In order to investigate the effects of proinflammatory cytokines on the integrity of intestinal 
epithelial junctions, the polarized HT-29 cF8 (clone F8) cell monolayer was exposed for 48 h to 
either IFNγ alone (50 ng/ml) or in combination with TNFα (10 ng/ml). Integrity of AJ was 
evaluated by immunolabeling of HT-29 cells with β-catenin, whereas TJ integrity was examined 
by immunolabeling of ZO-1. Confocal microscopy shows that IFNγ induces focal disruption of 
characteristic AJs, and TJs labeling (arrowheads), indicating junctional disassembly. TNFα 
dramatically exaggerates this effect. Together, these observations indicate that proinflammatory 
cytokines triggers disassembly of AJ and TJ in intestinal epithelial cells monolayer (Fig. 3.1).  
 
Figure 3.1. Proinflammatory cytokines induce disassembly of intestinal epithelial tight 
junctions and adherens junctions Confluent HT29 cell monolayers were treated for 48 h 
with either vehicle, IFNγ or a combination of IFNγ and TNFα. Localization of AJ and TJ 
proteins, β-cadherin and ZO-1, was determined by fluorescence labeling and confocal 
microscopy. IFNγ induces disappearance of AJ and TJ proteins from the areas of cell-cell 
contact (arrowheads), while TNFα potentiates IFNγ-driven junctional disassembly. 
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3.2 Proinflammatory Cytokines Decrease the Expression of TJs and AJs 
without Affecting their mRNA Levels. 
Given microscopy data revealing disassembly of AJ and TJ treated with cytokines in Figure 3.1, 
the effect of proinflammatory cytokines on the expression of different AJ and TJ proteins was 
next investigated. Human HT29 and T84 colonic epithelial cells monolayer were treated with 
either vehicle (PBS) IFNγ alone (50 ng/ml), and in combination with TNFα (10 ng/ml). Total 
cell lysate were prepared at 24 h and 48 h of cytokine exposure. Immunoblotting revealed the 
significant downregulation of AJ proteins (E-cadherin and p120 catenin) and the TJ protein 
(occludin) in cytokine-treated cells (Fig. 3.2A). By contrast, quantitative RT-PCR analysis did 
not reveal changes in mRNA expression of selected junctional proteins in cytokine-treated 
epithelial cells (Fig. 3.2B). These results indicate that proinflammatory cytokines disrupt the 
integrity of the intestinal epithelial barrier via expressional down-regulation of different AJ and 
TJ proteins. Such downregulation can occur without inhibition of mRNA transcription. 
 
Figure 3.2. Proinflammatory cytokines decrease the expression of intestinal epithelial tight junctions 
and adherens junctions without affecting their mRNA levels 
(A) Western blot analysis reveals that cytokines decrease expression of different AJ and TJ proteins in HT 
29 and T84 human intestinal epithelial cell lines. 
(B) Real time RT-PCR analysis of mRNA levels of selected junctional proteins in IFNγ and TNFα treated 
HT 29 cells. 
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3.3 Cytokines Decrease Expression of Different Translation Initiation Factors 
in Intestinal Epithelial Cell Lines 
Our data suggest that proinflammatory cytokines disrupt the integrity of epithelial junctions by 
decreasing expression of different AJ and TJ proteins at post-transcriptional level. We 
rationalized that this mechanism may involve inhibition of protein translation and especially its 
rate-limiting step: translation initiation. Therefore, we next sought to investigate the effects of 
proinflammatory cytokines on expression of major translation initiation factors. To do that, again 
we compared expression of eIF4G1 and eIF4G2 isoforms in control and IFNγ/TNFα of treated 
both HT-29 and T84 cells, along with expression of other components of the eIF4F cap-
dependent translation initiation complex (eIF4E). Cells were harvested for cell lysates on the 24h 
and 48h of the cytokine treatment. The immunoblotting analysis shows that exposure of T84 cell 
monolayers to either IFNγ or IFNγ plus TNFα resulted in dramatic downregulation of eIF4G1 
and eIF4G2 protein expression (Fig. 3.3A). Likewise, this cytokine combination reduced the 
expression of both eIF4G isoforms in HT-29 cells (Fig. 3.3B). The same inhibitory effects were 
evident for eIF4E expression. This data suggests that proinflammatory cytokines deplete major 
components of protein translation initiation machinery in intestinal epithelial cells in vitro. 
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Figure 3.3. Cytokines decrease expression of different translation initiation factors in 
intestinal epithelial cell lines in vitro. 
Representative immunoblots of HT 29 cells (A) and T84 (B) show that exposure of cells to 
either IFNγ or IFNγ plus TNFα markedly decreases levels of translation initiation factors 
eIF4G1, eIF4G2 and eIF4E.  
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3.4 Decreased Expression eIF4G2 in Intestinal Mucosa of IBD Patients 
 
Given our results that proinflammatory cytokines decrease expression of different translation 
initiation factors in vitro, we sought to examine if similar events may also happened during 
intestinal inflammation in vivo. In order to do that we performed dual immunofluorescence 
labeling of eIF4G2 (green) and β-catenin (red) in affected colonic sections of patients with a B2 
Montreal classification of Crohn’s disease, as well as normal colonic mucosa of patients 
undergoing intestinal surgery. The banked tissue sections were provided by Dr. John Kuemmerle 
from the GI Division at VCU Medical Center. As shown in figure 3.4, in normal colonic mucosa, 
eIF4G2 was abundantly expressed in epithelial cells (Fig. 3.4, arrows). In contrast, labeling 
intensity of this translational initiator was decreased in IBD mucosa (Fig. 3.4 arrowheads). 
Overall these data are consistent with in vitro experiment result on figure 3.3, mucosal 
inflammation decreases levels of eIF4G1 and eIF4G2 in intestinal epithelium in vitro and in vivo 
(Fig 3.4).  
 
 
Figure 3.4. Decreased expression of a translation initiation factor in inflamed human 
intestinal mucosa in vivo. 
Immunofluorescence images show diffuse eIF4G2 staining in normal colonic epithelia and marked 
reduction of eIF4G2 labelling in colonic mucosa of CD patient. 
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3.5 Knockdown of eIF4G1 and eIF4G2 Decreases Expression of Different AJ 
and TJ Proteins in Human Colonic Epithelial Cell Monolayers 
 
In order to investigate the role of eIF4G subunits on the integrity of epithelial junctions, the 
expression of two major eIF4G isoforms in epithelial cells was downregulated by using RNA 
interference (RNAi). To do that, eIF4G1 and eIF4G2 specific siRNA individual duplexes (D1-
D4) were used.  SK-CO15 human colonic epithelial cells were transfected with the control, 
eIF4G1, and eIF4G2 siRNA. The Expression of different AJ and TJ proteins was examined on 
day 4 post-transfection. Figure 3.3 shows that loss of these translation initiation factors decreases 
the expression of several junctional proteins. Interestingly, eIF4G1 appears to regulate the 
expression of both AJ and TJ proteins (Fig. 3.5A), whereas eIF4G2 was found to be a more 
selective regulator of TJ constituents (Fig. 3.5B). 
 
 
 
 
 
Figure 3.5. Knockdown of eIF4G1 and eIF4G2 decreases expression of different AJ and TJ proteins. 
SK-CO15 cells were transfected with either control, eIF4G1 or eIF4G2 siRNAs. Four days after the 
knockdown effects of eIF4G isoform knockdown on expression of different AJ and TJ proteins was 
determined by immunoblotting analysis. 
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3.6 siRNA-Mediated Depletion of eIF4G1 Prevents Formation of the 
Paracellular Barrier 
 
Since previous experiments indicate that, depletion of eIF4G1 and eIF4G2 downregulates the 
expression of different AJ and TJ proteins, we next sought to investigate the roles of these 
translation initiation factors on paracellular barrier formation and assembly of epithelial 
junctions. The initial series of experiments involved transient siRNA-mediated knockdown of 
eIF4G1. Paracellualr permeability was examined by measuring Transepithelial Electrical 
Resistance (TEER) from 2nd day through 4th day post transfection. We observed that loss of 
eIF4G1 in SK-CO15 cells significantly attenuate development of decreased TEER as compared 
to control siRNA-transfected cells (Fig. 3.6A). After measuring TEER, the cell monolayers were 
fixed and immunolabelled for β-catenin, occludin, claudin 4 (red) to visualize both AJ and TJ, 
and eIF4G1(Green) to visualize areas of its efficient knockdown. As a result, Figure 3.6B shows 
that depletion of eIF4G1 disrupted β-catenin and claudin-4 localization at apical junctions 
without having effect on occludin localization. Overall, these results suggest that eIF4G 
translation initiation factors play an essential role in the assembly of apical junctions and 
regulation of the intestinal epithelial barrier. 
 
 
Subsequent experiments were aimed at establishing SK-CO15 cell lines with stable shRNA-
mediated knockdown of either eIF4G1 or eIF4G2. These cell lines were created using protein-
specific shRNA plasmids cloned into a lentiviral vector. Ready to use lentiviral particles were 
obtained from Sigma, SK-CO15 cells were infected with these lentiviral particles and stable cell 
lines were generated after puromycin selection. Control, eIF4G1 or eIF4G2 depleted SK-CO15 
cells were plated on Transwell membrane filters, and TEER was measured on days 1-3 after the 
cells reached confluency. The results of this TEER measurement indicate that loss of either 
Eif4G1 or Eif4G2 impaired the development of the paracellular barrier (fig. 3.7).  
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Figure 3.6. siRNA-mediated depletion of eIF4G1 prevents formation of the paracellular 
barrier and attenuates AJ and TJ assembly.  
(A) TEER measurements demonstrate that eIF4G1-depleted SK-CO15 cell monolayers fail to 
develop the paracellular barrier. Data are presented as mean ± SE, n=3 *p<0.01.  
(B) Immunofluorescence labeling shows formation of normal β-catenin-based AJs and occludin 
and claudin 4-based TJs in control SK-CO15 cell monolayers on day 4 post-transfection. By 
contrast, eIF4G1-depleted cells have significant intracellular accumulation of β-catenin 
(arrowheads) and fragmented claudin4-based TJ strands (arrowheads). 
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Figure 3.7. shRNA-mediated depletion of eIF4G1 and eIF4G2 prevents the formation of the 
paracellular barrier in SK-CO15 cell lines. Control, eIF4G1 or eIF4G2-depleted SK-CO15 cells 
were plated on membrane filters and TEER was measured at indicated time points after cell reached 
confluency. Data are presented as mean ± SE, n=3 *p<0.01.  
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4. RESULTS- PART II 
 
4.1 Newly Synthesized Puromycin-Positive Nascent Polypeptide Chains are 
Present at the Leading Edge of Migrating Cells. 
Results of prior studies suggest that  protein translation machinery could be localized at  the 
leading edge of migrating individual cells such as fibroblasts [47, 50]. Based on these 
observations we started our study of the roles translation initiation in migration of intestinal 
epithelial cells by visualizing de novo protein translation in migrating cell monolayers.  In order 
to do that, we used Puromycin Incorporation Assay. This assay is based on structural similarity 
between puromycin amino acyl-transfer RNA (aminoacyl-tRNA), which allows for puromycin 
incorporation into a newly synthesized elongated polypeptide chain by forming a peptide 
bond[51]. Confluent HT-29 cell monolayers were wounded and allowed to migrate into the 
wound for 3 h. Then, 1µg/ml puromycin was added for additional 5 min.  Thereafter, cells were 
fixed and stained with anti-puromycin mAb to assess localization of de novo  protein translation 
in migrating cell monolayer [46]. Such pulse labeling with puromycin of the active sites of 
protein synthesis revealed that translation occurs exclusively at the leading edge of migrating 
epithelial sheet (Fig. 4.1). 
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Figure 4.1.  Newly synthesized puromycin-positive nascent polypeptide chains are present at 
the leading edge of migrating epithelial cells. Wounded HT 29 cell monolayers were, incubated for 
5 minutes with 1µg/ml puromycin, with subsequent fixation with anti-puromycin mAb (red). The 
cells were counterstained for filamentous actin (green). 
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4.2 Cell Migration Alters Intracellular Localization of eIF4G2 in Intestinal 
Epithelial Cells  
Because the results of previous experiments presented in figure 4.1 indicate that the nascent 
polypeptide chains are present at the leading edge of migrating cells, we next examined 
localization of eIF4G2 in stationary and migrating human intestinal epithelial cells. In this 
experiment, we used immortalized non-transformed HIEC cells, which are poorly differentiated 
stem cell like intestinal epithelial cells with high expression of eIF4G2. Immunoblotting analysis 
of eIF4G2 HIEC cells with a rabbit polyclonal antibody reveal a single bang of correct size, 
which disappeared after eIF4G2 knockdown, which indicates specificity of this antibody (data 
not shown). Surprisingly, we found that eIF4G2 was localized at nucleus in stationary cells 
intestinal epithelial cells (figure 4.2A). However, wound healing resulted to dramatic 
recolocalization of this translation initiation factor that become abundant in the cytosol and 
leading edge of the migrating cells (Figure 4.2B).  Together our immunolabeling experiments 
suggest that motility of intestinal epithelial cells could be driven by local translation of essential 
regulators of cell motility at the leading edge of migrating cells. 
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Figure 4.2. Confocal Images Showing Localization of eIF4G2 in Stationary (A) and 
Moving Cells (B). The confluent non-transformed HIEC cells were wounded by10μM 
pipette. Then cells were fixed and dual labelled for eIF4G2 (green) and F-actin (red). 
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4.3 Pharmacological Inhibition of the eIF4E-Dependent Protein Translation 
Attenuated Motility of Intestinal Epithelial Cell Monolayers 
 
The next series of experiments were designed to demonstrate causal roles of eIF4G-dependent 
translation initiation in the regulation of intestinal epithelial cell motility. Since eIF4G proteins 
regulate translation by interacting with eIF4E cap-dependent translation initiation factor, we used 
two pharmacological inhibitors that target different aspects eIF4E-dependent translation. One 
inhibitor is Ribavirin, an  anti-viral drug, which is known to decreases the affinity of eIF4E to m7 
G cap of mRNA[52]. For the other inhibitor is 4EGI-1, a small molecule which inhibits the 
binding between eIF4G proteins and eIF4E resulting in inhibiting the cap-dependent translation 
initiation [53]. The experiments with pharmacological inhibition of protein translation initiation 
were conducted in both poorly differentiated HIEC and well-differentiated T84 intestinal 
epithelial cells. Confluent HIEC and T84 cell monolayers were wounded and then allowed to 
migrate to close the wound in the presence of either vehicle, Ribavirin, or 4EGI-1. Images were 
obtained for HIEC cells at 0 h when the wound initiated and 12 h of wound closure. For T84 
cells, the images were taken at 0 h when the wound initiated and 24 h post wounding. As shown 
in Figures 4.3 and 4.4, a significant attenuation of wound closure by two inhibitors of translation 
initiation was observed in both cell lines. These results suggest that translation initiation is 
essential for collective migration of either stem cell-like or well-differentiated intestinal 
epithelial cells. 
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Figure 4.3. Ribavirin and 4EGI-1 attenuate the collective cell migration of HIEC cells. Effects 
of Ribavirin and 4EGI-1 inhibitors on the collective cell migration was determined by wound healing 
assay. HIEC cells were wounded and allowed to migrate in the presence of either vehicle, Ribavirin 
(20 μM), or 4EGI-1 (25 μM). The images were obtained in 0h and 12h post-wounding. 
Representative images of wounded monolayers (A) and quantification analysis of wound closure (B) 
are shown. Data are presented as mean ± SE, n=3 *p < 0.01.  
 
 
A 
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Figure 4.4. Ribavirin and 4EGI-1 attenuate the collective cell migration in T84 cells. Effects of 
Ribavirin and 4EGI-1 inhibitors on the collective cell migration was determined by wound healing 
assay. Confluent T84 cells were wounded and allowed to migrate in the presence of either vehicle, 
Ribavirin (20 μM), or 4EGI-1 (25 μM). The images were obtained in 0 h and 24 h post-wounding. The 
images were obtained in 0h and 12h post-wounded. Representative images of wounded monolayers 
(A) and quantification analysis of wound closure (B) are shown. Data are presented as mean ± SE, n=3 
*p < 0.01. 
 
A 
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4.4 Both eIF4G1 and eIF4G2 are Essential Regulators of Collective Migration 
of Intestinal Epithelial Cells 
Since our experiments with pharmacological inhibition of protein translation initiation 
demonstrated essential role of this process in the regulation of intestinal epithelial cell migration, 
we next sought to investigate if eIF4G1 and eIF4G2 play unique or redundant roles in cell 
motility. To address this question, we transiently and specifically down-regulated expression of 
each translation initiation protein in either HIEC or T84 intestinal epithelial cells and determined 
the effects of such knockdown on epithelial wound healing. Interestingly, loss of eIF4G2 
expression significantly attenuated collective migration of HIEC cells, whereas eIF4G1 
knockdown was ineffective (figure 4.5). By contrast depletion of either eIF4G1 or eIF4G2 
attenuated wound heling in T84 cell monolayers with similar efficiency (figure 4.6). These 
results highlight eIF4G2 as a universal regulator of intestinal epithelial cell motility 
independently of cell differentiation state. On the other hand, eIF4G1 appears to be dispensable 
for collective migration of stem like cells, but was required for migration of well-differentiated 
epithelial cells.   
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Figure 4.5. Depletion of eIF4G2 inhibits epithelial cell migration. Control, eIF4G1 and eIF4G2–
depleted HIEC cell monolayers were mechanically wounded on day 4 post-transfection. To examine 
the rate of cell motility, the cell-free area was measured at 0 and 10 h after wounding. Representative 
images of wounded monolayers (A) and quantification analysis of wound closure (B) are shown. 
Data are presented as mean ± SE, n=3 *p < 0.01. 
A 
B 
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Figure 4.6.  Depletion of eIF4G1 and eIF4G2 inhibits epithelial cell migration. Control, eIF4G1 
and eIF4G2–depleted T84 cell monolayers were mechanically wounded on day 4 posttransfection. 
To examine the rate of cell motility, the cell-free area was measured at 0 and 24h after wounding. 
Representative images of wounded monolayers (A) and quantification analysis of wound closure (B) 
are shown. Data are presented as mean ± SE, n=3 *p < 0.01. 
 
 
A 
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4.5 Depletion of eIF4G1 and eIF4G2 Decreases Individual Cell Migration of 
HIEC Cells. 
 
Wound healing assays captures just a single mode of collective cell migration. Therefore, we 
sought to expand our study to examine the roles of eIF4G1 and eIF4G2 in regulation of 
individual cell motility that could be essential for tumor cell dissemination. Individual motility of 
control, eIF4G1, or eIF4G2-depleted HIEC cells was examined by monitoring transfilter cell 
migration in the Boyden chamber. We found that depletion of either eIF4G1, or eIF4G2 
significantly decreased individual migration of HIEC cells with eIF4G1 depletion being more 
potent inhibitor of cell motility. Overall, these experiments suggest that eIF4G1 and eIF4G2 play 
non-redundant roles in regulating collective and individual migration of intestinal epithelial cells 
in vitro. eIF4G2 appears to be universal regulator of cell motility, whereas the involvement of 
eIF4G1 is more limited and depends on the experimental conditions(Fig.4.7). 
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Figure 4.7. Knockdown of eIF4G1 and eIF4G2 decrease transfilter migration of HIEC cells. 
HIEC Cells were transiently transfected with Control, eIF4G1, eIF4G2 siRNA. As described in 
materials and methods, Control, eIF4G1, and eIF4G2 depleted HIEC cells were subjected to 
Transfilter migration assay. The bar graph represents the number of cells migrated between control, 
eIF4G1, and eIF4G2 depleted HIEC cells. Data presented as mean ± SE, n=3   *p < 0.01, #p < 0.05. 
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4.6 eIF4G1 and eIF4G2 do not Regulate Cell- ECM Adhesion, while eIF4G2 is 
Essential Regulator of Cell Spreading  
 
Since cell migration is a multistep process we next sought to investigate which steps could be 
regulated by eIF4G1 and eIF4G2 in motile intestinal epithelial cells.  Cell adhesion to the ECM 
and cell spreading over ECM are initial steps of cell migration and are considered as the rate 
limiting steps, we investigated how these events could be affected by eIF4G1 and eIF4G2 
knockdown in HIEC cells. Figure 4.8 shows that transient depletion of eIF4G1 and eIF4G2 had 
not effect on the adhesion of HIEC cells to collagen I matrix. Furthermore, loss of o eIF4G1 did 
not affect cell spreading on collagen I (Fig. 4.9). By contrast depleted on eIF4G2 resulted in a 
dramatic increased the surface area of attached HIEC cells, thereby indicating the increased cell 
spreading (figure 4.9).   
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Figure 4.8. Knockdown of eIF4G1/eIF4G2 does not effect on epithelial cell-matrix adhesion. 
HIEC Cells were transiently transfected with Control, eIF4G1, eIF4G2 siRNA. The adhesion assay 
was performed using Control, eIF4G1, eIF4G2 knockdown cells on the 4th day post transfection. 
Note that there is no difference in the number of the cells adhered to the matrix between eIF4G1and 
eIF4G2 cells as compared to control cells. Fig.14A shows the images for stained Control, eIF4G1, 
eIF4G2 knockdown cells. Fig.14B shows the quantification of the adhesion assay.  
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Figure 4.9. eIF4G1, eIF4G2 knockdown accelerate cell spreading in HIEC cells. HIEC cells 
were transiently transfected with Control, eIF4G1, and eIF4G2 siRNA. The cell spreading assay was 
performed on the 4th day post transfection. 107 cells were loaded onto 24-well plates which were 
coated with Collagen type-1 overnight and were allowed to settle for one hour. Images were obtained 
by using high power microscope. Note that the eIF4G2 knockdown cells spread faster as compared 
to the control cells. Data presented as mean ± SE, n=3 *p < 0.01. 
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4.7 Loss of eIF4G1 Triggered Loss of Myoepithelial Phenotype in Stem Cell-
Like Intestinal Epithelial Cells  
 
While working with HIEC cells depleted of either eIF4G1, or eIF4G2  we  made a serendipitous 
observation that eIF4G1 deficiency caused dramatic alterations in cell shape. Indeed, control 
HIEC cells displayed an elongated spindle-like shape that is characteristic for either 
mesenchymal, or myoepithelial cells. By contrast, eIF4G1-depleted HIEC cells become 
orthogonal-shaped, which is more characteristic of epithelial cells (figure 4.10A). No significant 
alterations in cell shape was observed after eIF4G2 knockdown (figure 4.10A). In order to gain 
insights into molecular mechanisms that underline such dramatic cell shape changes, we 
performed immunoblotting analysis of expression of mesenchymal (vimentin) and myoepithelial 
(α-SMA, L-Caldesmon, and Sm 22) markers in these cells. Interestingly, eIF4G1 depletion did 
not change vimentin expression, but decreased the levels of all tested myoepithelial markers 
(figure 4.10B). Expectedly, no changes in expression of either mesenchymal or myoepithelial 
markers was observed in eIF4G2-depleted HIEC cells. Interestingly, loss of myoepithelial 
markers caused by eIF4G1 depletion was not accompanied by the induction of classical E-
cadherin (data not shown), which suggests that we did not observe a myoepithelial-to-epithelial 
transformation. Instead, loss of eIF4G1 is likely to transform HIEC in some yet to be 
characterized poorly-differentiated state. Importantly, all tested myoepithelial markers are 
important organizers and regulators of the intracellular actin cytoskeleton. Loss of these proteins 
is likely to disrupt normal organization of actin filament thereby contributing to inhibited 
motility of eIF4G1-depleted HIEC cells. 
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Figure 4.10. Altered cell shape and decreased expression of myoepithelial markers in  eIF4G1-
deficient HIEC cells.  (A) The effect of eIF4G1, or eIF4G2 depletion on HIEC cell shape was 
examined by using bright-field microscopy. B) Immunoblotting analysis of expression of 
mesenchymal and myoepithelial markers in total lysates of control, eIF4G1, or eIF4G2-depleted 
HIEC cells.  
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5. DISCUSSIONS 
 
5.1 Proinflammatory cytokines and their effect on translation of AJs and TJs 
proteins in intestinal epithelial cell monolayers; and on the protein 
translation initiation machinery. 
A number of previous studies[41, 54], and our initial interesting finding results (Fig.3.1, 3.2A), 
strongly suggest that proinflammatory cytokines disrupt the integrity of the intestinal epithelial 
barrier via expressional down-regulation of different AJ and TJ proteins. Such downregulation 
can occur without inhibition of mRNA transcription or enhanced degradation of junctional 
proteins[55-57] and is shown in Figure 3.2B. These findings are consistent with conclusion of 
our previous study on pancreatic epithelial cells (HPAF-II) [6], which demonstrated that the 
treated HPAF-II cells with IFNγ alone or the combination of  IFNγ plus TNFα weakens the 
pancreatic epithelial barrier by inducing the disassembly of pancreatic AJ and TJ proteins. Also, 
the expression of different AJs and TJs were downregulated by exposure to proinflammatory 
cytokines.  
Then, we determined the effects of proinflammatory cytokines on the protein translation 
initiation machinery. We examined if cytokine-induced expressional downregulation of different 
AJs and TJs proteins is accompanied by inhibition of eIF4G-dependent translation initiation in 
the intestinal epithelium. Expression of eIF4G1 and eIF4G2 isoforms was compared in control 
and IFNγ alone or combination with TNFα, in treated HT-29 and T84 cells, along with 
expression of other components of the eIF4F cap-dependent translation initiation complex 
(eIF4E). We observed that expression of intestinal epithelial eIF4G1, eIF4G2 and eIF4E is 
downregulated by proinflammatory in vitro. Likewise, we demonstrated the relevance of these 
findings to human IBD, and we performed dual immunolabeling of eIF4G2 and β-catenin in 
affected colonic sections of patients with a B2 Montreal classification of Crohn’s disease. We 
also used normal colonic section from patients undergoing intestinal surgery. We found that, in 
normal colonic mucosa, eIF4G2 was abundantly expressed in epithelial cells (Figure 3.4, 
arrows). In contrast, labeling intensity of this translational initiator was decreased in IBD mucosa 
(Figure 3.4 arrowheads). This finding is consistent with in vitro result in Figure 3.3, [58, 59]
 
and 
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suggests that mucosal inflammation decreases levels of eIF4G1 and eIF4G2 in intestinal 
epithelium in vivo.  
Our results (figures 3.3 and 3.4) are consistent with a previous study that demonstrated eIF4G1 
control of p120 catenin expression in IBC (inflammatory breast cancer). Overexpression of 
eIF4GI was observed in IBC, which is responsible for the pathological features of IBC such as, 
overexpression of E-cadherin, strong cancer cell interaction, tumor emboli formation, and IBC 
cell invasion. However, the downregulation of eIF4GI will block formation of tumor cell emboli 
by impairing cap-dependent mRNA translation of p120 [45]. 
In addition, there are many evidences indicating that the overexpression of eIF4GI has an 
oncogenic role and promotes the process of tumorigenesis. For example, overexpression of 
eIF4GI has been seen in different types of cancers: lung cancer, hypopharyngeal cancer, 
nasopharyngeal carcinoma (NPC), and IBC [45, 48, 60, 61]. 
Since our finding shows inhibition of eIF4G1 and eIF4G2 protein expression in cytokine- treated 
epithelial cells, there are two possible mechanisms of inhibition which we will explore in the 
future. The first mechanism comprises transcriptional downregulation of eIF4G isoforms, 
whereas another mechanism involves proteolytic degradation of these translational initiators. 
These two possibilities are consistent with previous studies which demonstrated caspase and 
calpain-dependent cleavage of eIF4G1 and eIF4G2 under different experimental conditions [62-
64]. 
5.2 eIF4G isoforms and their roles in regulating the structure and 
permeability of model intestinal epithelial barriers. 
Given our previous published paper, [6]  it has been shown that the proinflammatory cytokines 
induce permeability of human pancreatic epithelial monolayers, and that there is a decrease of  
the integrity of epithelial barrier which is revealed by decrease the TEER measurements. We 
want to investigate if the depletion of eIF4G isoforms, which correlates with downregulation in 
the expression of different AJs and TJs, has an effect on the integrity of intestinal epithelial 
barrier and permeability.  The results of this finding strongly suggest that the eIF4G isoforms 
(eIF4G1 and eIF4G2) have the important role in: regulation of the integrity and assembly of 
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epithelial AJs and TJs; and permeability of model intestinal epithelial barriers. This result is 
supported by two lines of evidence. The first is a significant decrease the expression of AJ and 
TJ proteins in depletion of eIF4G isoforms in intestinal epithelial cell monolayers (Figures 3.5A 
and 3.5B). The second evidence is that the eIF4G isoforms depletion prevents the formation of 
the paracellular barrier and attenuates AJ and TJ assembly. Also, eIF4G isoforms are known to 
control the translation of not only AJ and TJ components, but other different proteins [29, 65, 
66]. our experiments were designed to minimize the possible effects of altered cell motility and 
proliferation on junctional regulation. We have used two different approaches. One approach was 
involved in transient knockdown of eIF4G1 or eIF4G2 in SK-CO15 cells and HT 29 cells [67, 
68]. The second approach has involved the creation of stable inducible knockdown of eIF4G 
isoforms in SK-CO15 cells using a lentiviral transduction system [69]. As described in our  
recent lab papers [6, 70], paracellular permeability was examined by measuring transepithelial 
electrical resistance (TEER) in  siRNA transient knockdown for both eIF4G1 and eIF4G2, and 
shRNA-mediated knockdown for both eIF4G1 and eIF4G2. We found that TEER measurements 
demonstrate that the transient knockdown of eIF4G1 in SK-CO15 monolayers fails to develop 
the paracellular barrier and attenuates AJ and TJ assembly (figure 3.6). These findings agreed 
with the result of the shRNA-mediated depletion of eIF4G1 and eIF4G2 which shows that both 
depletion of eIF4G1 and eIF4G2 prevents the formation of the paracellular barrier in SK-CO15 
cell lines (figure 3.7). Generally, these findings are supported previous studies which suggested 
that the IBD and different intestinal and colorectal cancers increase the intestinal permeability 
[12].   
5.3 eIF4G isoforms localization. 
The localization of translational initiation factors is considered as a significant mechanism by 
which proteins were derived to their functional sites within cells [47]. Given previous studies 
from various groups of researchers who found that the protein translation machinery localizes on 
the leading edge of migrating fibroblasts [47, 50, 71], we want to investigate if similar actions 
happen during migration of intestinal epithelial cell monolayers. The protein translation on the 
leading edge was assessed by pulse-labeling of the cells with puromycin and immunolabeling of 
newly-translated proteins with anti-puromycin mAb, [46] as shown in Figure 4.1. We confirmed 
this result by the subsequent experiment which used wounded HIEC cell monolayers and we 
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immunolabeled it for eIF4G2 using commercially available antibodies. We found that eIF4G2 is 
localized on the cytoplasm of the leading edge of the migrating cell (figure 4.2B) compared to 
the stationary cell which has eIF4G2 localized in the nucleus (figure 4.2A). This finding suggests 
that the translation initiation machinery is active on the leading edge of migrating cells. 
5.4 Pharmacological inhibitors and their roles in cell migration and regulating 
the structure and permeability of model intestinal epithelial barriers. 
There are several multiple inhibitors which either work by the interaction between eIF4G and 
eIF4E or between the 5' cap of mRNA and eIF4E [52, 72, 73]. Ribavirin is one of the 
pharmacological inhibitors, which is considered as antiviral drug and structurally mimics to 5' 
cap of mRNA thus competing with eIF4E binding. It has been established through various 
studies that Ribavirin attenuates the migration and invasion of lung and breast cancer cells in 
vitro by reducing the wound closure. Also, this drug reduces the metastasis of pulmonary cancer 
cells, and blocks the growth of tumor cells in vivo. Additionally, it suppresses the TGFB-induced 
EMT and changes the shape of cells to be more epithelial-like round morphology in both 
NSCLC and in breast cancer cell lines by downregulating the expression of mesenchymal 
markers [74-76]. Another pharmacological inhibitor is eIF4E/eIF4G interaction inhibitor 1 
(4EGI-1), which is considered as an antitumor agent. It works allosterically by binding to eIF4E 
and prevents the interaction between eIF4E and eIF4G. Recent studies investigated the negative 
role of 4EGI-1 in breast CSCs (cancer stem cells) by inhibiting their proliferation and invasion. 
Also, 4EGI-1 inhibits breast CSC by inducing the apoptosis, and suppressing tumor angiogenesis 
and tumor growth in vivo[73, 77, 78]. In our study, we examined the effects of Ribavirin and 
4EGI-1 on the collective cell migration of intestinal epithelial monolayers, which involves HIEC 
(poorly differentiated cells) and T84 (well differentiated cells). We found that both Ribavirin and 
4EGI-1 decrease the collective cell migration in both cell lines compared to the control (figures 
4.3 and 4.4). These findings agree with previous studies which indicate the negative role of 
Ribavirin on cell migration[74, 76].  
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5.5 eIF4G isoforms and their effect on motility, ECM adhesion, and 
morphology of intestinal epithelial cells. 
Depletion of eIF4G isoforms proteins in intestinal epithelial cells was found to result in 
attenuated collective cell migration (fig. 4.5 and 4.6) and decreased transfilter migration of 
individual cells (fig. 4.7).  In the case of collective cell migration, there are two different results 
depending on the type of intestinal epithelial cell lines. For the HIEC cells, which is stem-cell-
like, the collective cell migration significantly decreased in knockdown of only eIF4G2. 
However, in T84 cell lines (well-differentiated cells), the wound closure was attenuated in 
depletion of both eIF4G1 and eIF4G2. These results agree with previously published study 
which reports that eIF4GI significantly attenuates the wound closure of NSCLC cell [74]. Our 
findings regarding molecular mechanisms that underlie the inhibited migration of eIF4G 
isoforms knockdown in intestinal epithelial cells created unsolved questions. The first 
mechanism, loss of eIF4G1 or eIF4G2 can decrease cell motility via downregulation of different 
FA proteins. Another mechanism is perhaps by inhibiting of Rac1 GTPase and its down-stream 
kinase PAK1, which is known to phosphorylate paxillin along with Src and FAK [79].  Because 
the ECM adhesion and cell spreading are the rate limiting steps of cell migration, we have 
supported our finding results by examining the cell adhesion and cell spreading in HIEC cells. 
We found that there is no change in the ECM adhesion over collagen type 1 in depletion of 
eIF4G isoforms, whereas the cell spreading was significantly increased in eIF4G2 depletion (fig. 
4.8 and 4.9). These findings maybe explain the decreased velocity of cell migration in HIEC 
cells. In order to investigate if knockdown of eIF4G isoforms has an effect on EMT, we 
examined the morphology of the confluent HIEC cells in shRNA-mediated knockdown of both 
eIF4G1 and eIF4G2. We found that in the case of eIF4G1, the cells become more epithelial- like 
rounded cells compared to control and eIF4G2 depletion, which appear as a more fibroblast-like 
spindle shape (fig. 4.10A). Accordingly, we examined the expression of different myo-epithelial 
markers by immunoblotting. We found that the decrease in the expression of myo-epithelial 
markers, which involve alpha-SMA, L-caldesmon, and sm22, in eIF4G1 depletion. However, 
there is no change in one of EMT marker vimentin (fig.4.10B). These findings are consistent 
with the previous study which suggest that knockdown of eIF4G1 in NSCLC cell lines is 
induced by changing the morphology of the cells to be more epithelial-like round 
morphology[74]. 
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6. CONCLUSION 
 
our study suggests that loss of intestinal epithelial eIF4G isoforms play essential roles in 
disruption of the mucosal barrier by decreasing the expression of different AJs and TJs proteins; 
and attenuating epithelial integrity and restitution by inducing disassembly of intestinal epithelial 
TJs and AJs. Furthermore, the loss of eIF4G isoforms markedly attenuates epithelial wound 
closure depending on the type of the cells. Also, the depletion of eIF4G isoforms decreases the 
transfilter migration of individual cells. Finally, our studies have shown that knockdown of 
eIF4G1 and eIF4G2 have no effect on ECM adhesion, whereas the depletion of eIF4G2 has a 
positive effect on cell spreading by increasing the cell surface area. However, further studies 
need to confirm this hypothesis. 
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7. Future Directions 
In order to study the effect of eIF4G isoforms depletion with different intestinal epithelial cell 
lines, HIEC, HT-29, SK-CO15 and T84 with stable shRNA-mediated knockdown and lentiviral 
CRISP/CAS9 knockout system of either eIF4G1 or eIF4G2 will be used to perform all the 
mentioned assays in this thesis. Also, we will overexpress select AJ and TJ proteins (p120 
catenin, E-cadherin, claudin-4, and some others) in eIF4G1 or eIF4G2-depleted epithelial cells 
using an internal ribosomal entry site (IRES) to determine if overexpression of junctional 
proteins can restore barrier function and junctional integrity in eIF4G- deficient cells. 
Additionally, we want to elucidate if overexpression of eIF4G isoforms ameliorates cytokine-
induced defects of apical junctions and disruption of the epithelial barrier. These gain of function 
experiments have two major goals. One is to examine if the increased expression of eIF4G1 and 
eIF4G2 can enhance normal epithelial barrier. The other goal is to demonstrate a causal role of 
eIF4G isoform downregulation in the cytokine-induced breakdown of the model intestinal 
epithelial barrier. Also, we are interested in determining the effects of chronic mucosal 
inflammation on global protein translation and the translation initiation machinery, in vivo. 
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